多医院整合医疗网络中妊娠期CT肺动脉造影辐射剂量的预测因素
本回顾性研究评估2012年1月至2017年4月多医院整合医疗网络中因疑诊肺栓塞首次接受CT肺动脉造影的孕妇,共534例检查,平均有效辐射剂量为3.96 mSv;双变量分析显示不同孕期辐射剂量存在显著差异(P=0.042),多变量分析表明孕早期、较高mAs、kVp、扫描长度、患者体型、使用mAs调制及较低螺距可预测更高的有效辐射剂量。
要点
- 妊娠期CTPA平均有效辐射剂量为3.96 mSv。
- 孕早期CTPA辐射剂量(4.52 mSv)高于孕中期(3.73 mSv)和孕晚期(3.95 mSv),整体差异P=0.042。
- 孕早期、高mAs、高kVp、长扫描长度、大体型、mAs调制及低螺距预测更高辐射剂量。
核心结论
- 平均有效辐射剂量处于已发表研究范围的较低端。
- 在纳入已知辐射剂量预测因素后,孕期仍是有效辐射剂量的统计学显著预测因素。
研究设计与样本
- 回顾性研究,纳入2012年1月至2017年4月多医院整合医疗网络中因评估肺栓塞而首次接受CTPA的孕妇,共534例检查。
- 患者及CT相关数据来自电子健康记录和Radimetrics服务器(Radimetrics Inc, Bayer)。
- 记录DLP,使用转换因子0.014 mSv·mGy⁻¹·cm⁻¹计算有效辐射剂量(mSv)。
- 患者体型通过水当量直径确定。
- 基于患者和CT因素对有效辐射剂量进行双变量和多变量分析。
诊断标准与关键数值
- 平均有效辐射剂量为3.96 mSv(共534例CTPA检查)。
- 双变量分析显示不同孕期辐射剂量存在显著差异,P=0.042:孕早期4.52 mSv,孕中期3.73 mSv,孕晚期3.95 mSv。
- 多变量分析显示以下因素可预测更高的有效辐射剂量:孕早期接受CTPA、mAs增加、kVp增加、扫描长度增加、患者体型增大、使用mAs调制以及螺距降低。
临床应用与阅片要点
- 妊娠期CTPA的平均有效辐射剂量为3.96 mSv。
- 孕早期CTPA的辐射剂量(4.52 mSv)高于孕中期(3.73 mSv)和孕晚期(3.95 mSv)。
- 孕早期、较高mAs、较高kVp、较长扫描长度、较大患者体型、使用mAs调制及较低螺距与更高的有效辐射剂量相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: There is a large range of published effective radiation dose for CTPA during pregnancy. The purpose of our study is to determine the mean effective radiation dose and predictors of mean effective radiation dose for CTPA in pregnant patients across a multihospital integrated healthcare network.
METHODS: This retrospective study evaluates pregnant women who had a CTPA as the first primary advanced imaging test for evaluation of PE in a multihospital integrated healthcare network from January 2012-April 2017. Patient and CT-related data were obtained from the electronic health record and Radimetrics server (Radimetrics Inc, Bayer). DLP was recorded and effective radiation dose in mSv was determined using a conversation factor of 0.014 mSv·mGy-¹·cm-¹. Patient size was determined by water equivalent diameter. Bivariate and multivariate analysis were performed for effective radiation dose based on patient and CT factors.
RESULTS: In the 534 CTPA exams, the mean effective radiation dose was 3.96 mSv. Bivariate analysis showed significant differences in radiation dose by trimester, p = 0.042: first trimester 4.52 mSv, second trimester 3.73 mSv, and third trimester 3.95 mSv. Multivariable analysis demonstrated CTPA during first trimester, increasing mAs, kVp, scan length, patient size, and use of mAs modulation, as well as decreasing pitch, to be predictive of higher effective radiation dose.
CONCLUSION: Mean effective radiation dose was on the lower end of published studies. Trimester was a statistically significant predictor of effective radiation dose when accounting for known predictors of radiation dose.
引用
- Cohen SL, Wang JJ, Chan N, et al. Predictors of radiation dose for CT pulmonary angiography in pregnancy across a multihospital integrated healthcare network. Eur J Radiol. 2019. PMID: 31711025. doi:10.1016/j.ejrad.2019.108721
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。